Ultime notizie per Stratasys (NASDAQ:SSYS) Azioni

Stratasys

Stratasys Ltd is a polymer-based 3D printing solution, which provides a product life cycle, with multiple technologies and complete solutions for superior application fit, across industrial, healthcare, and consumer fields. It focuses, in particular, on polymer 3D printing solutions that address the fastest-growing manufacturing solutions viewed as the potential growth opportunity in the 3D printing industry. Its printers include FDM, PolyJet, Stereolithography, P3, and SAF. Its software is GrabCAD Software, Connectivity, Digital Anatomy Creator, and OpenAM Software. It generates revenue through 3D printing systems, related services, and consumables and by providing additive manufacturing solutions.

Stratasys Ltd

U.S. stocks were mixed, with the Dow Jones index gaining around 200 points on Monday.
Shares of Alcoa Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AA#NYSE">AA</a>) rose sharply during Monday's session after the company agreed to sell its 25.1% joint venture stake in Ma&#8217;aden for $1.1 billion, including $950 million <a href="https://www.benzinga.com/markets/equities/24/09/40873786/alcoa-pockets-1-1b-from-saudi-joint-venture-sale-details">in Ma&#8217;aden shares.</a>
Alcoa shares jumped 6.5% to $34.63 on Monday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Ascendis Pharma A/S (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASND#NASDAQ">ASND</a>) shares jumped 19.8% to $142.76 after the company announced topline data from its pivotal approach trial of Transcon CNP (Navepegritide).</li>
<li>Bausch + Lomb Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLCO#NASDAQ">BLCO</a>) shares gained 15% to $17.86. Needham reiterated a Hold rating on Bausch &amp; Lomb.</li>
<li>Nuvalent, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUVL#NASDAQ">NUVL</a>) climbed 12.8% to $98.70 after the company highlighted results for its ROS1 and ALK-Positive NSCLC programs and accelerated its development timeline. Also, the company announced a $350 million public offering and multiple firms raised their respective price targets on the stock.</li>
<li>Fitell Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTEL#NASDAQ">FTEL</a>) gained 12.5% to $17.75.</li>
<li>JBDI Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JBDI#NASDAQ">JBDI</a>) jumped 11.1% to $29.38.</li>
<li>Lattice Semiconductor Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSCC#NASDAQ">LSCC</a>) surged 10.3% to $49.46. Lattice Semiconductor appointed Ford Tamer as CEO, effective immediately.</li>
<li>EchoStar Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SATS#NASDAQ">SATS</a>) rose 8.4% to $26.33. Morgan Stanley, on Friday, raised its price target on the stock from $14 to $20.</li>
<li>Stratasys Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSYS#NASDAQ">SSYS</a>) rose 7.9% to $7.61 after the company authorized a share repurchase program of up to $50 million.</li>
<li>Corvus Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRVS#NASDAQ">CRVS</a>) gained 7.5% to $5.48. The announced it initiated the registrational Phase 3 clinical trial of Soquelitinib for patients with relapsed or refractory peripheral T-cell lymphoma.</li>
<li>Viasat, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSAT#NASDAQ">VSAT</a>) rose 6.3% to $13.57.</li>
<li>Hertz Global Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTZ#NASDAQ">HTZ</a>) rose 5.5% to $3.1650.</li>
<li>Sprouts Farmers Market, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFM#NASDAQ">SFM</a>) gained 4.2% to $106.42. Evercore ISI Group analyst Michael Morris upgraded Sprouts Farmers Market from In-Line to Outperform and raised the price target from $96 to $120.</li>
</ul>
Now Read This:<a href="https://www.benzinga.com/24/09/40876800/this-analyst-with-86-accuracy-rate-sees-around-9-upside-in-rh-here-are-5-stock-picks-for-last-week-f"> </a>
<ul>
<li><a href="https://www.benzinga.com/24/09/40876800/this-analyst-with-86-accuracy-rate-sees-around-9-upside-in-rh-here-are-5-stock-picks-for-last-week-f">This Analyst With 86% Accuracy Rate Sees Around 9% Upside In RH &#8211; Here Are 5 Stock Picks For Last Week From Wall Street&#8217;s Most Accurate Analysts</a></li>
</ul>

News

Intraday Update

Markets

Movers

Trading Ideas

ASND

BLCO

CRVS

FTEL

JBDI

LSCC

NUVL

SATS

SSYS

VSAT

Alcoa, Lattice Semiconductor, Stratasys And Other Big Stocks Moving Higher On Monday

Stratasys, Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSYS#NASDAQ">SSYS</a>) shares are trading higher premarket Monday after the company approved a <a target="_blank" href="https://www.benzinga.com/pressreleases/24/09/b40872730/stratasys-announces-board-authorization-of-50-million-share-repurchase-program" rel="noreferrer noopener">$50 million share repurchase program</a>.
The repurchase program is part of Stratasys&#8217; strategy to enhance shareholder value and follows its restructuring plan, which aims to save $40 million annually starting in the first quarter of 2025.
The plan included a 15% workforce reduction by year-end and a focus on high-growth products and solutions, along <a target="_blank" href="https://www.benzinga.com/news/earnings/24/08/40624869/stratasys-q2-earnings-loss-widens-cuts-workforce-lowers-annual-projections-stock-tumbles" rel="noreferrer noopener">with achieving annualized EBITDA margins of 8%</a>.
Yoav Zeif, Stratasys&#8217; Chief Executive Officer, said, &#8220;Our focus is on generating significantly higher profit and cash flow by driving revenue, aligning costs and reinvesting in growth initiatives. In addition, we intend to return value to shareholders through a share repurchase program that reflects the Board&#8217;s confidence in our strategy and ability to deliver long-term profitable growth.&#8221;
Last month, the company reported fiscal second-quarter 2024 revenue of $138.04&nbsp;million, missing the&nbsp;analyst consensus estimate of $146.34 million. Adjusted EPS loss of 0.04 cents&nbsp;beat the&nbsp;analyst consensus estimate of 5 cent&nbsp;loss.
Stratasys held cash and equivalents of $150.86 million at the end of the second quarter of 2024.
Investors can gain exposure to the stock via&nbsp;Pacer BlueStar Engineering the Future ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BULD#NASDAQ">BULD</a>).
Price Action: SSYS shares are up 4.68% at $7.38 premarket at the last check Monday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/08/40652006/stratasys-analysts-cut-their-forecasts-after-q2-results" target="_blank" rel="noreferrer noopener">Stratasys Analysts Cut Their Forecasts After Q2 Results</a></li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Equities

Buybacks

Small Cap

BULD

Why Is 3D Printing Company Stratasys Stock Surging Today?

WIIM

Stratasys shares are trading higher after the company authorized a share repurchase program of up to $50 million.

General

Stratasys Has Authorized A Share Repurchase Program Of Up To $50M

Up to 50% Improvement in File Processing and Printing Speeds of Complex High-Quality Patterns
New Processor Supports Faster Time to Market for Metal Cast Parts
In collaboration with Materialise, Stratasys Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSYS#NASDAQ">SSYS</a>) today announced the launch of the Stratasys Neo&#xAE; Build Processor for Investment Casting, a unique solution designed to accelerate the production of high-quality investment casting master patterns.
This new build processor, developed for Stratasys Neo&#xAE;450 and Neo&#xAE;800 stereolithography (SLA) 3D printers, offers up to 50% faster file processing and significantly enhanced print speeds, streamlining the 3D printing workflow for manufacturers and service bureaus in the aerospace and other demanding industries.
3D printing master patterns can reduce the investment casting production time from weeks to days, potentially resulting in up to 75% time savings compared to traditional methods of manufacturing, including wax mold and CNC machining. The ability to rapidly produce intricate designs that were previously unachievable with conventional techniques opens up new possibilities for innovation in part design and functionality, specifically with small-series production runs.

Stratasys and Materialise Announces Manufacturers Can Now Quickly Produce High-Quality Master Patterns For Investment Casting Production With New 3D Printing Build Processor

Loop Capital analyst Ananda Baruah maintains Stratasys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSYS#NASDAQ">SSYS</a>) with a Hold and lowers the price target from $9 to $7.

Price Target

Analyst Ratings

Loop Capital Maintains Hold on Stratasys, Lowers Price Target to $7

Stratasys Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSYS#NASDAQ">SSYS</a>) reported worse-than-expected second-quarter sales and cut its <a href="https://www.benzinga.com/quote/SSYS/earnings">FY24 guidance on Thursday.</a>
Stratasys reported fiscal second-quarter 2024 revenue of $138.04million, missing the analyst consensus estimate of $146.34 million. Adjusted EPS loss of 4 cents beat the analyst consensus estimate of 5 cent loss.
The company shared plans to downsize its workforce by 15% by 2024 end to save $40 million in annual cost beginning in the first quarter of 2025, along with annualized EBITDA margins of 8%.
Stratasys cut FY24 revenue outlook to $570 million—$580 million (prior $630 million—$645 million) against a consensus of $631.63 million. The company lowered the adjusted EPS outlook to $0.01-$0.05 (prior $0.12-$0.19) versus the consensus $0.15. Stratasys also lowered the adjusted EBITDA outlook to $24 million—$27 million (prior $40 million—$45 million) and adjusted operating margins of 0.5%—1.0% (prior 2.5%—3.5%). The company also expects positive cash flow from operating activities.
Stratasys expects its third-quarter revenue to be slightly higher than second-quarter revenue versus the $160.78 million consensus estimate.
Stratasys shares dipped 9.9% to close at $6.92 on Thursday.
These analysts made changes to their price targets on Stratasys following earnings announcement.
<ul>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/591b27b4290fa70001b1563e/james-ricchiuti">Needham analyst James Ricchiuti </a>maintained Stratasys with a Buy and lowered the price target from $12 to $10.</li>
<li>Lake Street analyst Troy Jensen maintained the stock with a Buy and lowered the price target from $15 to $11.</li>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/585939beee7bf600010fe940/troy-jensen">Cantor Fitzgerald analyst Troy Jensen</a> maintained Stratasys with an Overweight and cut the price target from $23 to $12.</li>
</ul>
Considering buying SSYS stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="509" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/30092710/image-323-1024x509.png" alt="" class="wp-image-523214" style="width:561px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/30092710/image-323-1024x509.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/30092710/image-323-300x149.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/30092710/image-323-768x382.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/30092710/image-323.png 1328w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>

Earnings

Stratasys Analysts Cut Their Forecasts After Q2 Results

Cantor Fitzgerald analyst Troy Jensen maintains Stratasys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSYS#NASDAQ">SSYS</a>) with a Overweight and lowers the price target from $23 to $12.

Cantor Fitzgerald Maintains Overweight on Stratasys, Lowers Price Target to $12

Lake Street analyst Troy Jensen maintains Stratasys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSYS#NASDAQ">SSYS</a>) with a Buy and lowers the price target from $15 to $11.

Lake Street Maintains Buy on Stratasys, Lowers Price Target to $11

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page.</a>
<ul>
<li>Mizuho raised the price target for Autodesk, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADSK#NASDAQ">ADSK</a>) from $230 to $260. Mizuho analyst Matthew Broome maintained a Neutral rating. Autodesk shares gained 1.4% to close at $258.23 on Thursday. <a href="https://www.benzinga.com/quote/ADSK/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Morgan Stanley increased the price target for MongoDB, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDB#NASDAQ">MDB</a>) from $320 to $340. Morgan Stanley analyst Sanjit Singh maintained an Overweight rating. MongoDB shares gained 4.4% to close at $245.72 on Thursday. <a href="https://www.benzinga.com/quote/MDB/analyst-ratings">See how other analysts view this stock.</a></li>
<li>B of A Securities raised Victoria&#8217;s Secret &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VSCO#NYSE">VSCO</a>) price target from $18 to $21. B of A Securities analyst Alice Xiao maintained an Underperform rating. Victoria&#8217;s Secret shares fell 3.7% to close at $23.96 on Thursday. <a href="https://www.benzinga.com/quote/VSCO/analyst-ratings">See how other analysts view this stock.</a></li>
<li>HSBC boosted the price target for CrowdStrike Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) from $302 to $339. HSBC analyst Stephen Bersey upgraded the stock from Hold to Buy. CrowdStrike shares gained 2.8% to close at $271.67 on Thursday. <a href="https://www.benzinga.com/quote/CRWD/analyst-ratings">See how other analysts view this stock.</a></li>
<li>TD Cowen cut Kohl&#8217;s Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KSS#NYSE">KSS</a>) price target from $25 to $21. TD Cowen analyst Oliver Chen downgraded the stock from Buy to Hold. Kohl&#8217;s shares gained 0.6% to close at $19.77 on Thursday. <a href="https://www.benzinga.com/quote/KSS/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Piper Sandler raised Autodesk, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADSK#NASDAQ">ADSK</a>) price target from $239 to $257. Piper Sandler analyst Clarke Jeffries maintained a Neutral rating. Autodesk shares gained 1.4% to close at $258.23 on Thursday. <a href="https://www.benzinga.com/quote/ADSK/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Baird slashed the price target for Elastic N.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESTC#NYSE">ESTC</a>) from $135 to $95. Baird analyst Shrenik Kothari downgraded the stock from Outperform to Neutral. Elastic shares rose 0.6% to close at $103.64 on Thursday. <a href="https://www.benzinga.com/quote/ESTC/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Morgan Stanley cut Dollar General Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DG#NYSE">DG</a>) price target from $170 to $100. Morgan Stanley analyst Simeon Gutman downgraded the stock from Overweight to Equal-Weight. Dollar General shares fell 32.2% to close at $84.03 on Thursday. <a href="https://www.benzinga.com/quote/DG/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Needham slashed Stratasys Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSYS#NASDAQ">SSYS</a>) price target from $12 to $10. Needham analyst James Ricchiuti maintained a Buy rating. Stratasys shares fell 9.9% to close at $6.92 on Thursday. <a href="https://www.benzinga.com/quote/SSYS/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Loop Capital raised Best Buy Co., Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBY#NYSE">BBY</a>) price target from $100 to $110. Loop Capital analyst Anthony Chukumba maintained a Buy rating. Best Buy shares gained 14.1% to close at $100.18 on Thursday. <a href="https://www.benzinga.com/quote/BBY/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying CRWD stock? Here&#8217;s what analysts think:
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="553" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/30081045/image-316-1024x553.png" alt="" class="wp-image-522976" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/30081045/image-316-1024x553.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/30081045/image-316-300x162.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/30081045/image-316-768x415.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/30081045/image-316.png 1338w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>

Pre-Market Outlook

ADSK

CRWD

ESTC

VSCO

CrowdStrike To Rally Around 25%? Here Are 10 Top Analyst Forecasts For Friday

Needham analyst James Ricchiuti maintains Stratasys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSYS#NASDAQ">SSYS</a>) with a Buy and lowers the price target from $12 to $10.

Needham Maintains Buy on Stratasys, Lowers Price Target to $10

Stratasys (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ssys#NASDAQ">SSYS</a>) came out with a quarterly loss of $0.04 per share in line with the Zacks Consensus Estimate. This compares to earnings of $0.04 per share a year ago. These figures are adjusted for non-recurring items.
A quarter ago, it was expected that this maker of 3D printers would post a loss of $0.04 per share when it actually produced a loss of $0.02, delivering a surprise of 50%.
Over the last four quarters, the company has surpassed consensus EPS estimates just once.
Stratasys, which belongs to the Zacks Computer - Peripheral Equipment industry, posted revenues of $138.04 million for the quarter ended June 2024, missing the Zacks Consensus Estimate by 6.78%. This compares to year-ago revenues of $159.75 million. The company has topped consensus revenue estimates just once over the last four quarters.
The sustainability of the stock&#39;s immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management&#39;s commentary on the earnings call.
Stratasys shares have lost about 46.2% since the beginning of the year versus the S&amp;P 500&#39;s gain of 17.2%.
<h2>What&#39;s Next for Stratasys?</h2>
While Stratasys has underperformed the market so far this year, the question that comes to investors&#39; minds is: what&#39;s next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company&#39;s earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Stratasys: mixed. While the magnitude and direction of estimate revisions could change following the company&#39;s just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future.
It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus EPS estimate is $0.07 on $165.07 million in revenues for the coming quarter and $0.14 on $631.49 million in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Computer - Peripheral Equipment is currently in the top 4% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
One other stock from the broader Zacks Computer and Technology sector, Asana, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/asan#NYSE">ASAN</a>), is yet to report results for the quarter ended July 2024. The results are expected to be released on September 3.
This company is expected to post quarterly loss of $0.08 per share in its upcoming report, which represents a year-over-year change of -100%. The consensus EPS estimate for the quarter has been revised 0.8% lower over the last 30 days to the current level.
Asana, Inc.&#39;s revenues are expected to be $177.44 million, up 9.2% from the year-ago quarter.
<a href="https://www.zacks.com/stock/news/2328718/stratasys-ssys-reports-q2-loss-lags-revenue-estimates?cid=CS-BENZ-FT-tale_of_the_tape|yseop_template_4-2328718">To read this article on Zacks.com click here.</a>

Mid Cap

ASAN

Stratasys Reports Q2 Loss, Lags Revenue Estimates

Stratasys, Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSYS#NASDAQ">SSYS</a>)&nbsp;stock tanked after the company reported fiscal second-quarter 2024 revenue of $138.04&nbsp;million, missing the&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/24/08/b40621708/stratasys-releases-second-quarter-2024-financial-results" rel="noreferrer noopener">analyst consensus estimate of $146.34 million</a>.
Adjusted EPS loss of 0.04 cents&nbsp;beat the <a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">analyst consensus estimate of 5 cent</a> loss.
The adjusted gross margin expanded to 49.0% from 48.5% a year ago. Adjusted operating loss was $(3.2) million, down from $5.0 million a year ago.
Adjusted net loss was $(3.0) million, down from $2.5 million a year ago. Adjusted EBITDA fell to $2.3 million from $10.6 million the prior year.
Cash used in operations stood at $(2.4) million, compared to $(23.2) million a year ago. Stratasys held cash and equivalents of $150.86 million.
The company shared plans to downsize its workforce by 15% by 2024 end to save $40 million in annual cost beginning in the first quarter of 2025, along with annualized EBITDA margins of 8%.
FY24 Outlook: Stratasys cut revenue outlook to $570 million—$580 million (prior $630 million—$645 million) against a <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">consensus of $631.63 million</a>.
The company lowered the adjusted EPS outlook to $0.01-$0.05 (<a target="_blank" href="https://www.benzinga.com/news/earnings/24/03/37541791/stratasys-surges-on-revenue-beat-eyes-growth-amid-additive-manufacturing-innovation" rel="noreferrer noopener">prior $0.12-$0.19</a>) versus the consensus $0.15.
Stratasys also lowered the adjusted EBITDA outlook to $24 million—$27 million (prior $40 million—$45 million) and adjusted operating margins of 0.5%—1.0% (prior 2.5%—3.5%). The company also expects positive cash flow from operating activities.
Stratasys expects its third-quarter revenue to be slightly higher than second-quarter revenue versus the $160.78 million consensus estimate.
Stratasys&nbsp;stock plunged over 45% in the last 12 months.
Price Action: SSYS stock traded lower by 15.2% at $6.51 premarket at the last check on Thursday.

Guidance

Tech

Stratasys Q2 Earnings: Loss Widens, Cuts Workforce, Lowers Annual Projections, Stock Tumbles

Business Update:
Following a comprehensive strategic review, Stratasys is taking focused restructuring actions to further strengthen its industry leading balance sheet and robust business model to more effectively weather all market cycles. The initiatives are expected to support ongoing focused innovation investments and facilitate wider adoption of additive manufacturing.
Effective immediately, the Company will streamline operations and enhance its go to market strategy to focus on the highest growth potential products, materials and software solutions. By the end of this year, the Company will have rightsized its workforce by approximately 15%. These steps are expected to produce approximately $40 million in annual cost savings beginning in the first quarter of 2025, along with annualized EBITDA margins of 8% at current revenue levels. Furthermore, in addition to sustainable profitability, the Company will remain well-positioned to act upon opportunities that may arise.

Stratasys Announces 15% Workforce Reduction, Aiming for $40M Annual Savings

Stratasys shares are trading lower after the company reported worse-than-expected Q2 sales and cut its FY24 revenue and earnings guidance.

2024 Financial Outlook:
Based on current market conditions and assuming that the impacts of global inflationary pressures, relatively high interest rates and supply chain costs do not impede economic activity further, the Company is updating its outlook for the full year 2024 as follows:
<ul>
<li>Revenue of $570 million to $580 million.
<ul>
<li>Third quarter revenue slightly higher than second quarter revenue.</li>
</ul>
</li>
<li>Non-GAAP gross margin of 48.7% to 49.0%.</li>
<li>Operating expenses of $276 million to $278 million.</li>
<li>Non-GAAP operating margin of 0.5% to 1.0%.</li>
<li>GAAP net loss of $106 million to $91 million, or ($1.50) to ($1.29) per diluted share.
<ul>
<li>Includes one-time extraordinary costs associated with Stratasys' strategic alternatives process.</li>
</ul>
</li>
<li>Non-GAAP net income of $1 million to $4 million, or $0.01 to $0.05 per diluted share.</li>
<li>Adjusted EBITDA of $24 million to $27 million.</li>
<li>Capital expenditures of $20 million to $25 million.</li>
</ul>
Non-GAAP earnings guidance excludes $30 million to $32 million of share-based compensation expense, $25 million to $27 million of projected amortization of intangible assets, and reorganization and other expenses of $39 million to $45 million. Non-GAAP guidance includes tax adjustments of $2 million to $3 million on the above non-GAAP items.

Stratasys Expects FY24 Revenue Of $570M-$580M (Prior $630M-$645M) Vs $631.63M Est, Adj EPS Of $0.01-$0.05 (Prior $0.12-$0.19) Vs $0.15 Est

Earnings Beats

Earnings Misses

Stratasys Q2 2024 Adj. EPS $(0.04) Beats $(0.05) Estimate, Sales $138.041M Miss $146.339M Estimate

Stratasys (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ssys#NASDAQ">SSYS</a>) is slated to release second-quarter 2024 results on Aug. 29.
The Zacks Consensus Estimate for Stratasys&#39; second-quarter revenues is pegged at $148.08 million, indicating a year-over-year decrease of 7.31%. The consensus mark for the bottom line is pegged at a loss of 4 cents per share. SSYS posted non-GAAP earnings of 4 cents per share in the year-ago quarter.
Its earnings beat the Zacks Consensus Estimate twice in the trailing four quarters, matched once and missed once, the average surprise being 58.33%.
Let&#39;s see how things have shaped up before the upcoming announcement.
<div class="chart_embed">
<h2>Stratasys, Ltd. Price and EPS Surprise</h2>
<img alt="Stratasys, Ltd. Price and EPS Surprise" src="https://staticx-tuner.zacks.com/images/charts/d5/1724762436.png" style="height:310px; width:620px" title="" />
Stratasys, Ltd. price-eps-surprise | Stratasys, Ltd. Quote
</div>
<h2>Factors to Consider</h2>
The year-over-year expected decline in top and bottom lines is due to divestitures of certain businesses and unfavorable foreign currency exchange rates. Nonetheless, Stratasys&#39; second-quarter performance is likely to have benefited from steady demand for its products and solutions.
With many engineers, designers, architects and entrepreneurs resorting to 3D solutions for their primary designing and product modeling, the 3D printing market is becoming a favorable long-term investment opportunity. This trend is likely to have spurred the demand for Stratasys&#39; 3D products and solutions in the second quarter. In the quarter to be reported, Stratasys announced its new SAF HighDef Printing capabilities and the launch of the H350 printer, Version 1.5 (V.1.5), to expand SAF adoption with additional applications and use cases for a growing set of manufacturing end markets.
SSYS also launched the J5 Digital Anatomy 3D printer, which is designed to meet the rising need for affordable and high-fidelity anatomical models. An improvement in product quality and performance, along with multiple product launches, is expected to have boosted the firm&#39;s performance.
The company announced updates to several Industrial and Healthcare Business Unit products and Stratasys Direct. These include a new open platform for the F900 3D printer, more on-demand 3D printing capabilities and a new high-performance material for its Fused Deposition Modeling line. These product launches with enhanced capabilities are likely to have helped the company gain new customers in the to-be-reported quarter.
However, the weakening global economy amid ongoing macroeconomic issues has led enterprises to postpone their large IT spending plans. This might have hurt Stratasys&#39; top line in the second quarter. Additionally, inflation and increased component costs are likely to have weighed on Stratasys&#39; profitability in the quarter.
<h2>What Our Model Says</h2>
Our proven model does not conclusively predict an earnings beat for SSYS this season. The combination of a positive Earnings ESP and Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. However, that&#39;s not the case here.
Though Stratasys currently carries a Zacks Rank of 3, it has an Earnings ESP of 0.00%.
<h2>Stocks With the Favorable Combination</h2>
Here are some stocks worth considering, as our model shows that these have the right combination of elements to beat on earnings in their upcoming releases.
Abercrombie &amp; Fitch (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/anf#NYSE">ANF</a>) has an Earnings ESP of +3.50% and carries a Zacks Rank #2 at present.
Abercrombie &amp; Fitch is slated to report its second-quarter 2024 results on Aug 28. The Zacks Consensus Estimate for the company&#39;s earnings is pegged at $2.13 per share, indicating a significant improvement of 93.6% from the prior-year quarter&#39;s figure of $1.10. Shares of ANF have returned 92.5% in the year-to-date period.
Affirm (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/afrm#NASDAQ">AFRM</a>) has an Earnings ESP of +19.64% and carries a Zacks Rank #3 at present.
The company is scheduled to release fourth-quarter fiscal 2024 results on Aug 28. The Zacks Consensus Estimate for Affirm&#39;s loss is pegged at 45 cents per share, narrower than the prior-year quarter&#39;s loss of 69 cents. Shares of Affirm have plunged 36% in the year-to-date period.
American Eagle Outfitters (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aeo#NYSE">AEO</a>) has an Earnings ESP of +1.97% and carries a Zacks Rank #3 at present.
The company is set to report second-quarter fiscal 2024 results on Aug 29. The Zacks Consensus Estimate for AEO&#39;s earnings is pegged at 38 cents per share, which indicates an improvement of 52% from the year-ago quarter&#39;s reported figure. Shares of American Eagle Outfitters have gained 4.8% in the year-to-date period.
<a href="https://www.zacks.com/stock/news/2327846/stratasys-gears-up-to-report-q2-earnings-key-factors-to-note?cid=CS-BENZ-FT-analyst_blog|earnings_preview-2327846">To read this article on Zacks.com click here.</a>

AFRM

Stratasys Gears Up to Report Q2 Earnings: Key Factors to Note

CollPlant Biotechnologies&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/clgn#NASDAQ">CLGN</a>) and Stratasys Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ssys#NASDAQ">SSYS</a>) recently announced the initiation of a pre-clinical study with 200cc commercial-sized regenerative implants printed on a Stratasys Origin 3D printer.
The study is likely to focus on the ability of implants to grow natural breast tissue and completely degrade over time. As part of the study, 3D printed breast implants consisting of 200cc in the volume of CollPlant&#39;s rhCollagen-based bioinks produced on a Stratasys&#39; Origin printer are to be tested. The pre-clinical study marks a significant step forward in the companies&#39; combined effort to provide patients with care using regenerative medicine instead of traditional implants.
<h3>More on the News</h3>
While CollPlant is a cutting-edge firm in regenerative and aesthetic medicine, creating innovative technologies and products based on its rhCollagen for tissue regeneration and organ production, Stratasys is a leader in polymer 3D printing solutions. Stratasys modified the Origin printer to print the regenerative implants after the two companies announced a collaboration in April 2023. CollPlant is expecting to have initial results from the study in the first half of 2025.
The collaboration between CollPlant and Stratasys is currently focused on developing a bioprinting solution for CollPlant&#39;s breast implants as well as ways to expedite the implant&#39;s construction process. The goal of the study is to evaluate the implants&#39; capacity to stimulate the formation of native breast tissue and eventually degrade entirely.
A substantial share of the total addressable breast implant market is likely to be captured by CollPlant&#39;s innovative breast implants, which are designed to regenerate an individual&#39;s natural breast tissue without triggering an immune reaction. These implants could offer a ground-breaking substitute for reconstructive and cosmetic procedures.
<h3>Industry Prospects</h3>
Per a report by The Brainy Insights, the global breast implant market is estimated to be $3 billion, while breast reconstruction and augmentation procedures represent the second most common plastic surgery procedure performed worldwide.
The most common breast augmentation or reconstruction procedures utilize synthetic breast implantations made of silicone, an artificial substitution for natural regenerated tissue with a risk of complications.
<h3>Price Performance</h3>
For the year-to-date period, CLGN&#39;s shares have lost 24.1% against the industry&#39;s rise of 0.2%. The S&amp;P 500 increased 17.7% in the same time frame.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/1d/74826.jpg?v=1569553057" />
Image Source: Zacks Investment Research
<h3>Zacks Rank &amp; Stocks to Consider</h3>
CLGN carries a Zacks Rank #3 (Hold) at present.
Some better-ranked stocks in the broader medical space are&nbsp;Universal Health Service&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/uhs#NYSE">UHS</a>) and&nbsp;ABM Industries&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/abm#NYSE">ABM</a>). While Universal Health Service sports a Zacks Rank #1 (Strong Buy), ABM Industries carries a Zacks Rank #2 (Buy).
Universal Health Service has an estimated long-term growth rate of 19%. UHS&#39; earnings surpassed estimates in each of the trailing four quarters, with the average being 14.58%.
Universal Health Service has gained 41.1% compared with the&nbsp;industry&#39;s&nbsp;34.8% rise so far this year.
ABM Industries&#39; earnings surpassed estimates in each of the trailing four quarters, delivering an average surprise of 7.34%.
ABM&#39;s shares have risen 24.1% so far this year compared with the&nbsp;industry&#39;s&nbsp;11.9% growth.
<a href="https://www.zacks.com/stock/news/2325247/collplant-clgn-stratasys-initiate-study-for-breast-implants?cid=CS-BENZ-FT-analyst_blog|company_news_medical_sector-2325247">To read this article on Zacks.com click here.</a>

Biotech

Large Cap

Penny Stocks

CLGN

CollPlant, Stratasys Initiate Study for Breast Implants

3D Printed Breast implants consisting of 200cc in volume of CollPlant's rhCollagen-based bioinks produced on a Stratasys' Origin&#174; printer to be tested
Technology innovation addresses a $3.0 billion market opportunity
Study to focus on ability of implants to grow natural breast tissue and completely degrade over time
In a significant step in the advancement of regenerative medicine, CollPlant Biotechnologies (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/clgn#NASDAQ">CLGN</a>) and Stratasys Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ssys#NASDAQ">SSYS</a>) today announced the initiation of a pre-clinical study with 200cc commercial-sized regenerative implants printed on a Stratasys Origin&#174; 3D printer.
The collaboration between CollPlant and Stratasys is currently focused on the development of a bioprinting solution for CollPlant's breast implants, in addition to finding solutions to scale-up the implant's fabrication process. The study is intended to test the ability of the implants to promote the growth of natural breast tissue and completely degrade over time.
CollPlant's novel breast implants have been designed to regenerate an individual's natural breast tissue without eliciting an immune response, and could provide a revolutionary alternative for both reconstructive and aesthetic procedures, which represents a significant portion of the overall $3 billion addressable breast implant market.

CollPlant And Stratasys Begin Pre-Clinical Study Of 3D-Printed 200cc Regenerative Breast Implants Using CollPlant's rhCollagen-Based Bioinks On Stratasys' Origin Printer

Warning: SSYS is at high risk of performing badly

Stratasys announces $50M share repurchase program

Stratasys (SSYS) has released an update. Stratasys Ltd. has announced a new $50 million share repurchase program as part of their strategic actions...

Stratasys Launches $50 Million Share Buyback

Biggest stock movers today: DJT, INTC, BLCO and more

There's a lot to be optimistic about in the Technology sector as 3 analysts just weighed in on Cellebrite DI (CLBT – Research Report), Stratasys (S...

Analysts Offer Insights on Technology Companies: Cellebrite DI (CLBT), Stratasys (SSYS) and Mitek Systems (MITK)

Biggest stock movers today: AAPL, DJT, INTC, BLCO and more

Stratasys: Surviving The Slowdown

Stratasys (SSYS) has released an update. Stratasys Ltd. has announced its 2024 Annual General Meeting scheduled for November 7, 2024, in Israel, wi...

Stratasys Schedules 2024 Annual Shareholders Meeting

There's a lot to be optimistic about in the Technology sector as 3 analysts just weighed in on Zeta Global Holdings Corp (ZETA – Research Report), ...

Analysts Offer Insights on Technology Companies: Zeta Global Holdings Corp (ZETA), Stratasys (SSYS) and IonQ (IONQ)

Stratasys (SSYS) has released an update. Stratasys Ltd. has announced its 2024 Annual General Meeting of Shareholders, scheduled for November 7, 20...

Stratasys Schedules 2024 Shareholders Meeting

AAPL

BTSG

CLBT

INTC

IONQ

MITK

UPST

ZETA

Press Releases

CollPlant and Stratasys Announce Pre-clinical Study for Regenerative Commercial-Sized Breast Implants

COLLPLANT BIOTECHNOLOGIES REPORTS 2024 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

Stratasys Releases Second Quarter 2024 Financial Results

Stratasys Unveils Game-changing Printing Solution with High Precision for Manufacturers Seeking Short Production Runs

Stratasys Demonstrating at IMTS How Today's Manufacturers use Additive Manufacturing Across the Production Cycle, Improving Both Business and Part Performance

Manufacturers Can Now Quickly Produce High-Quality Master Patterns for Investment Casting Production with New 3D Printing Build Processor from Stratasys and Materialise

Momentum of Stratasys' F3300 Printer Indicates Global Manufacturers Are Turning to AM to Solve Their Toughest Production Challenges

Stratasys Announces Board Authorization of $50 Million Share Repurchase Program

Stratasys Announces 2024 Annual General Meeting of Shareholders

Stratasys Introduces a New Era of Precision and Efficiency in 3D Printed Fashion

Comments

Stratasys

Notizie

Ultime notizie per Stratasys (NASDAQ:SSYS) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO